VRTX
Vertex Pharmaceuticals Incorporated
- Depreciation and amortization, 2025
- $210M
- YoY, 2025
- +1.3%
- 5-year CAGR
- +13.9%
- 10-year CAGR
- +12.9%
Depreciation and amortization
Depreciation and amortization by fiscal year
| Period | D&A | YoY |
|---|---|---|
| 2025 | $210M | +1.3% |
| 2024 | $207M | +14.3% |
| 2023 | $181M | +22.3% |
| 2022 | $148M | +18.1% |
| 2021 | $126M | +14.7% |
| 2020 | $110M | +2.4% |
| 2019 | $107M | +47.6% |
| 2018 | $72M | +18.0% |
| 2017 | $61M | 0.0% |
| 2016 | $61M | −1.5% |
| 2015 | $62M | −1.4% |
| 2014 | $63M | +30.8% |
| 2013 | $48M | +26.6% |
| 2012 | $38M | +9.0% |
| 2011 | $35M | +15.0% |
| 2010 | $30M | +1.2% |
| 2009 | $30M | −6.5% |
| 2008 | $32M | — |